GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Provexis PLC (AQSE:PXS.GB) » Definitions » Total Liabilities

Provexis (AQSE:PXS.GB) Total Liabilities : £0.47 Mil (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is Provexis Total Liabilities?

Provexis's Total Liabilities for the quarter that ended in Sep. 2024 was £0.47 Mil.

Provexis's quarterly Total Liabilities declined from Sep. 2023 (£0.32 Mil) to Mar. 2024 (£0.31 Mil) but then increased from Mar. 2024 (£0.31 Mil) to Sep. 2024 (£0.47 Mil).

Provexis's annual Total Liabilities increased from Mar. 2022 (£0.16 Mil) to Mar. 2023 (£0.19 Mil) and increased from Mar. 2023 (£0.19 Mil) to Mar. 2024 (£0.31 Mil).


Provexis Total Liabilities Historical Data

The historical data trend for Provexis's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Provexis Total Liabilities Chart

Provexis Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.15 0.16 0.19 0.31

Provexis Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.19 0.32 0.31 0.47

Provexis Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Provexis's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities=Total Assets (A: Mar. 2024 )-Total Equity (A: Mar. 2024 )
=0.498-0.191
=0.31

Provexis's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities=Total Assets (Q: Sep. 2024 )-Total Equity (Q: Sep. 2024 )
=0.822-0.351
=0.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Provexis Total Liabilities Related Terms

Thank you for viewing the detailed overview of Provexis's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Provexis Business Description

Traded in Other Exchanges
Address
2 Blagrave Street, I Ford, Reading, Berkshire, GBR, RG1 1AZ
Provexis PLC is a British food company. It is engaged in developing and licensing the Fruitflow, which is patented, natural, breakthrough ingredient which helps with platelet aggregation. Fruitflow reduces the propensity for aberrant blood clotting, typically associated with cardiovascular disease, which can result in heart attack and stroke. The extract is available in two formats, a syrup and a powder, and it can be included in a broad range of food, beverage and dietary supplement formats.

Provexis Headlines

No Headlines